{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T17:45:14Z","timestamp":1769622314830,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T00:00:00Z","timestamp":1370476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T00:00:00Z","timestamp":1370476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep01947","type":"journal-article","created":{"date-parts":[[2013,6,6]],"date-time":"2013-06-06T09:08:32Z","timestamp":1370509712000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Placenta-derived gp96 as a multivalent prophylactic cancer vaccine"],"prefix":"10.1038","volume":"3","author":[{"given":"Bao","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanzhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erjie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HongXia","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MingMing","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lizhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songdong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,6]]},"reference":[{"key":"BFsrep01947_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1038\/471S2a","volume":"471","author":"T O'Callaghan","year":"2011","unstructured":"O'Callaghan, T. Introduction: The prevention agenda. Nature 471, S2\u20134 (2011).","journal-title":"Nature"},{"key":"BFsrep01947_CR2","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1098\/rstb.2011.0101","volume":"366","author":"MA Liu","year":"2011","unstructured":"Liu, M. A. Cancer vaccines. Philos Trans R Soc Lond B Biol Sci 366, 2823\u20132826 (2011).","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"BFsrep01947_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3109\/07853890.2011.565065","volume":"43","author":"VK Tuohy","year":"2011","unstructured":"Tuohy, V. K. & Jaini, R. Prophylactic cancer vaccination by targeting functional non-self. Ann Med 43, 356\u2013365 (2011).","journal-title":"Ann Med"},{"key":"BFsrep01947_CR4","doi-asserted-by":"publisher","first-page":"4853","DOI":"10.1182\/blood-2011-01-329656","volume":"118","author":"H Pere","year":"2011","unstructured":"Pere, H. et al. A CCR4 antagonist combined with vaccines induces antigen-specific CD8(+) T cells and tumor immunity against self antigens. Blood 118, 4853\u20134862 (2011).","journal-title":"Blood"},{"key":"BFsrep01947_CR5","doi-asserted-by":"publisher","first-page":"11037","DOI":"10.1158\/0008-5472.CAN-07-2499","volume":"67","author":"P Nanni","year":"2007","unstructured":"Nanni, P. et al. Antimetastatic activity of a preventive cancer vaccine. Cancer Res 67, 11037\u201311044 (2007).","journal-title":"Cancer Res"},{"key":"BFsrep01947_CR6","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/nm.2161","volume":"16","author":"R Jaini","year":"2010","unstructured":"Jaini, R. et al. An autoimmune-mediated strategy for prophylactic breast cancer vaccination. Nat Med 16, 799\u2013803 (2010).","journal-title":"Nat Med"},{"key":"BFsrep01947_CR7","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.yexmp.2008.12.002","volume":"86","author":"BG Brewer","year":"2009","unstructured":"Brewer, B. G., Mitchell, R. A., Harandi, A. & Eaton, J. W. Embryonic vaccines against cancer: An early history. Exp Mol Pathol 86, 192\u2013197 (2009).","journal-title":"Exp Mol Pathol"},{"key":"BFsrep01947_CR8","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1007\/s00262-010-0899-9","volume":"59","author":"W Dong","year":"2010","unstructured":"Dong, W. et al. Administration of embryonic stem cells generates effective antitumor immunity in mice with minor and heavy tumor load. Cancer Immunol Immun 59, 1697\u20131705 (2010).","journal-title":"Cancer Immunol Immun"},{"key":"BFsrep01947_CR9","doi-asserted-by":"publisher","first-page":"e42289","DOI":"10.1371\/journal.pone.0042289","volume":"7","author":"K Yaddanapudi","year":"2012","unstructured":"Yaddanapudi, K. et al. Vaccination with Embryonic Stem Cells Protects against Lung Cancer: Is a Broad-Spectrum Prophylactic Vaccine against Cancer Possible? PloS one 7, e42289 (2012).","journal-title":"PloS one"},{"key":"BFsrep01947_CR10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1158\/0008-5472.CAN-07-0445","volume":"68","author":"L Garcia-Hernandez Mde","year":"2008","unstructured":"Garcia-Hernandez Mde, L., Gray, A., Hubby, B., Klinger, O. J. & Kast, W. M. Prostate stem cell antigen vaccination induces a long-term protective immune response against prostate cancer in the absence of autoimmunity. Cancer Res 68, 861\u2013869 (2008).","journal-title":"Cancer Res"},{"key":"BFsrep01947_CR11","doi-asserted-by":"publisher","first-page":"5478","DOI":"10.1073\/pnas.0508035103","volume":"103","author":"R Sood","year":"2006","unstructured":"Sood, R., Zehnder, J. L., Druzin, M. L. & Brown, P. O. Gene expression patterns in human placenta. P Natl Acad Sci USA 103, 5478\u20135483 (2006).","journal-title":"P Natl Acad Sci USA"},{"key":"BFsrep01947_CR12","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.4049\/jimmunol.180.5.3176","volume":"180","author":"J Robert","year":"2008","unstructured":"Robert, J., Ramanayake, T., Maniero, G. D., Morales, H. & Chida, A. S. Phylogenetic conservation of glycoprotein 96 ability to interact with CD91 and facilitate antigen cross-presentation. J Immunol 180, 3176\u20133182 (2008).","journal-title":"J Immunol"},{"key":"BFsrep01947_CR13","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.4049\/jimmunol.0902368","volume":"184","author":"LE Kropp","year":"2010","unstructured":"Kropp, L. E., Garg, M. & Binder, R. J. Ovalbumin-derived precursor peptides are transferred sequentially from gp96 and calreticulin to MHC class I in the endoplasmic reticulum. J Immunol 184, 5619\u20135627 (2010).","journal-title":"J Immunol"},{"key":"BFsrep01947_CR14","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0140-6736(00)04050-2","volume":"357","author":"SD Meng","year":"2001","unstructured":"Meng, S. D., Gao, T., Gao, G. F. & Tien, P. HBV-specific peptide associated with heat-shock protein gp96. Lancet 357, 528\u2013529 (2001).","journal-title":"Lancet"},{"key":"BFsrep01947_CR15","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1002\/eji.200939593","volume":"39","author":"Z Liu","year":"2009","unstructured":"Liu, Z. et al. Treg suppress CTL responses upon immunization with HSP gp96. Eur J Immunol 39, 3110\u20133120 (2009).","journal-title":"Eur J Immunol"},{"key":"BFsrep01947_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/ncomms1524","volume":"2","author":"S Pawaria","year":"2011","unstructured":"Pawaria, S. & Binder, R. J. CD91-dependent programming of T-helper cell responses following heat shock protein immunization. Nat Commun 2, 521 (2011).","journal-title":"Nat Commun"},{"key":"BFsrep01947_CR17","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.immuni.2006.12.005","volume":"26","author":"Y Yang","year":"2007","unstructured":"Yang, Y. et al. Heat shock protein gp96 is a master chaperone for toll-like receptors and is important in the innate function of macrophages. Immunity 26, 215\u2013226 (2007).","journal-title":"Immunity"},{"key":"BFsrep01947_CR18","doi-asserted-by":"publisher","first-page":"22545","DOI":"10.1074\/jbc.M502900200","volume":"281","author":"T Warger","year":"2006","unstructured":"Warger, T. et al. Interaction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responses. J Biol Chem 281, 22545\u201322553 (2006).","journal-title":"J Biol Chem"},{"key":"BFsrep01947_CR19","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.1073\/pnas.0308180101","volume":"101","author":"RJ Binder","year":"2004","unstructured":"Binder, R. J. & Srivastava, P. K. Essential role of CD91 in re-presentation of gp96-chaperoned peptides. P Natl Acad Sci USA 101, 6128\u20136133 (2004).","journal-title":"P Natl Acad Sci USA"},{"key":"BFsrep01947_CR20","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1002\/ijc.27332","volume":"130","author":"M Randazzo","year":"2012","unstructured":"Randazzo, M., Terness, P., Opelz, G. & Kleist, C. Active-specific immunotherapy of human cancers with the heat shock protein Gp96-revisited. Int. J. Cancer 130, 2219\u20132231 (2012).","journal-title":"Int. J. Cancer"},{"key":"BFsrep01947_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0022-1759(02)00093-5","volume":"264","author":"SD Meng","year":"2002","unstructured":"Meng, S. D., Song, J., Rao, Z. H., Tien, P. & Gao, G. F. Three-step purification of gp96 from human liver tumor tissues suitable for isolation of gp96-bound peptides. J Immunol Methods 264, 29\u201335 (2002).","journal-title":"J Immunol Methods"},{"key":"BFsrep01947_CR22","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1007\/s00262-011-1076-5","volume":"60","author":"XL Yan","year":"2011","unstructured":"Yan, X. L. et al. Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity. Cancer Immunol Immun 60, 1763\u20131774 (2011).","journal-title":"Cancer Immunol Immun"},{"key":"BFsrep01947_CR23","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.4049\/jimmunol.171.8.4054","volume":"171","author":"MH Manjili","year":"2003","unstructured":"Manjili, M. H. et al. HSP110-HER2\/neu chaperone complex vaccine induces protective immunity against spontaneous mammary tumors in HER-2\/neu transgenic mice. J Immunol 171, 4054\u20134061 (2003).","journal-title":"J Immunol"},{"key":"BFsrep01947_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cellimm.2006.07.002","volume":"240","author":"J Jacob","year":"2006","unstructured":"Jacob, J. et al. Activity of DNA vaccines encoding self or heterologous Her-2\/neu in Her-2 or neu transgenic mice. Cell Immunol 240, 96\u2013106 (2006).","journal-title":"Cell Immunol"},{"key":"BFsrep01947_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.4049\/jimmunol.0902255","volume":"184","author":"JL Gong","year":"2010","unstructured":"Gong, J. L. et al. A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use. J Immunol 184, 488\u2013496 (2010).","journal-title":"J Immunol"},{"key":"BFsrep01947_CR26","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/bies.200900025","volume":"31","author":"U Hobohm","year":"2009","unstructured":"Hobohm, U. Toward general prophylactic cancer vaccination. Bioessays 31, 1071\u20131079 (2009).","journal-title":"Bioessays"},{"key":"BFsrep01947_CR27","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1038\/471S8a","volume":"471","author":"M Eisenstein","year":"2011","unstructured":"Eisenstein, M. Vaccines: Know your enemy. Nature 471, S8\u2013S9 (2011).","journal-title":"Nature"},{"key":"BFsrep01947_CR28","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1128\/JVI.01710-12","volume":"87","author":"J Hao","year":"2013","unstructured":"Hao, J. et al. Inhibition of alpha interferon (IFN-alpha)-induced microRNA-122 negatively affects the anti-hepatitis B virus efficiency of IFN-alpha. J Virol 87, 137\u2013147 (2013).","journal-title":"J Virol"},{"key":"BFsrep01947_CR29","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep01947","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep01947.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep01947.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:38:37Z","timestamp":1672983517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep01947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,6]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,20]]}},"alternative-id":["BFsrep01947"],"URL":"https:\/\/doi.org\/10.1038\/srep01947","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,6]]},"assertion":[{"value":"8 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1947"}}